# Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD

> **NCT05066282** · — · COMPLETED · sponsor: **Resilient Pharmaceuticals** · enrollment: 186 (actual)

## Conditions studied

- PTSD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05066282
- **Lead sponsor:** Resilient Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2024-05-16
- **Final completion:** 2024-05-21
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2024-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05066282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05066282, "Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05066282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*